Recent studies have reported that CHSY1 was overexpressed in various tumors (for example, hepatocellular carcinoma [24], glioma [25], soft tissue sarcomas[26]), demonstrating its possible association with tumor progression. Here, CHSY1 is linked to central nervous system cancer.